| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.979 | 0.001 | 0.979 | Gastric antisecretory | 0.946 0.001 DBMET01822 0.939 0.001 DBMET00184 | ||
| 0.976 | 0.001 | 0.976 | Potassium channel (ATP-sensitive) blocker | 0.83 0.001 DBMET01822 0.493 0.002 DBMET00184 | ||
| 0.925 | 0.001 | 0.925 | H+/K+-transporting ATPase inhibitor | 0.863 0.001 DBMET01822 0.741 0.001 DBMET00184 | ||
| 0.899 | 0.001 | 0.899 | Antibacterial (Helicobacter pylori) | 0.8 0.002 DBMET01822 0.579 0.003 DBMET00184 | ||
| 0.686 | 0.005 | 0.686 | Potassium channel blocker | 0.592 0.005 DBMET01822 | ||
| 0.536 | 0.003 | 0.536 | ABCA1 expression enhancer | 0.482 0.004 DBMET01822 0.34 0.005 DBMET00184 | ||
| 0.512 | 0.002 | 0.512 | Potassium channel (Inward rectifier) blocker | 0.407 0.002 DBMET01822 0.202 0.004 DBMET00184 | ||
| 0.464 | 0.003 | 0.479 | ATPase inhibitor | 0.479 0.003 DBMET01822 0.198 0.039 DBMET00184 | DBMET01822 | |
| 0.436 | 0.004 | 0.436 | Gastrin inhibitor | 0.334 0.015 DBMET01822 0.274 0.054 DBMET00184 | ||
| 0.402 | 0.005 | 0.402 | Ca(v)3.3 blocker | 0.336 0.019 DBMET01822 0.402 0.005 DBMET00184 | ||
| 0.385 | 0.007 | 0.385 | Interleukin 1 antagonist | 0.225 0.024 DBMET01822 0.239 0.021 DBMET00184 | ||
| 0.432 | 0.059 | 0.487 | Histamine release inhibitor | 0.487 0.034 DBMET01822 | DBMET01822 | |
| 0.361 | 0.043 | 0.361 | Calcium channel activator | 0.32 0.073 DBMET01822 0.293 0.099 DBMET00184 | ||
| 0.288 | 0.009 | 0.288 | Interleukin 1b antagonist | 0.16 0.033 DBMET01822 0.182 0.024 DBMET00184 | ||
| 0.264 | 0.004 | 0.264 | Histamine H2 receptor antagonist | 0.119 0.021 DBMET01822 0.081 0.063 DBMET00184 | ||
| 0.217 | 0.076 | 0.217 | Interleukin antagonist | 0.143 0.123 DBMET00184 | ||
| 0.169 | 0.028 | 0.169 | MAP kinase 13 inhibitor | 0.095 0.09 DBMET00184 | ||
| 0.172 | 0.032 | 0.172 | MAP kinase 12 inhibitor | 0.105 0.091 DBMET00184 | ||
| 0.286 | 0.146 | 0.401 | Antibacterial | 0.401 0.077 DBMET01822 | DBMET01822 | |
| 0.141 | 0.005 | 0.141 | Fatty acid synthase inhibitor | 0.061 0.034 DBMET01822 | ||
| 0.137 | 0.045 | 0.137 | Alpha 2b adrenoreceptor antagonist | 0.106 0.069 DBMET01822 | ||
| 0.112 | 0.022 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.106 0.026 DBMET01822 | ||
| 0.134 | 0.051 | 0.136 | Sphingosine 1-phosphate receptor 4 antagonist | 0.136 0.048 DBMET00184 | DBMET00184 | |
| 0.143 | 0.065 | 0.143 | Bone formation stimulant | 0.135 0.072 DBMET01822 | ||
| 0.1 | 0.023 | 0.115 | Ca(v)3.1 blocker | 0.081 0.057 DBMET01822 0.115 0.013 DBMET00184 | DBMET00184 | |
| 0.106 | 0.042 | 0.106 | Phosphodiesterase 6D inhibitor | |||
| 0.07 | 0.01 | 0.07 | Histamine H2 receptor agonist | |||
| 0.186 | 0.132 | 0.186 | Spasmolytic | 0.16 0.154 DBMET01822 | ||
| 0.154 | 0.111 | 0.159 | P-glycoprotein inhibitor | 0.159 0.103 DBMET01822 | DBMET01822 | |
| 0.082 | 0.046 | 0.082 | Viral attachment inhibitor | |||
| 0.065 | 0.03 | 0.077 | Ca(v)3.2 blocker | 0.055 0.052 DBMET01822 0.077 0.017 DBMET00184 | DBMET00184 | |
| 0.076 | 0.051 | 0.076 | MAP kinase 11 inhibitor | |||
| 0.103 | 0.079 | 0.103 | Calcium channel (voltage-sensitive) blocker | 0.103 0.08 DBMET01822 | ||
| 0.056 | 0.042 | 0.059 | Acetyl-CoA transferase 2 inhibitor | 0.058 0.035 DBMET01822 0.059 0.034 DBMET00184 | DBMET00184 | |
| 0.107 | 0.116 | 0.269 | Cyclooxygenase inhibitor | 0.269 0.023 DBMET00184 | DBMET00184 | |
| 0.102 | 0.113 | 0.11 | Calcium channel blocker | 0.11 0.1 DBMET01822 | DBMET01822 | |
| 0.065 | 0.164 | 0.252 | Cyclooxygenase 1 inhibitor | 0.252 0.021 DBMET00184 | DBMET00184 | |
| 0.06 | 0.177 | 0.234 | Cyclooxygenase 2 inhibitor | 0.234 0.023 DBMET00184 | DBMET00184 | |
| 0.077 | 0.432 | 0.259 | Transcription factor inhibitor | 0.259 0.181 DBMET00184 | DBMET00184 | |
| 0.12 | 0.511 | 0.41 | Calcium channel L-type activator | 0.41 0.074 DBMET01822 | DBMET01822 | |
| 0.039 | 0.476 | 0.405 | Thioredoxin glutathione reductase inhibitor | 0.405 0.055 DBMET00184 | DBMET00184 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |